…, E Dominguez, G Fregoso, N Ortiz, WM Weiss… - Current opinion in …, 2021 - Elsevier
Bone tissue engineering (BTE) aims to develop strategies to regenerate damaged or diseased bone using a combination of cells, growth factors, and biomaterials. This article highlights …
The characterization of cancer genomes has provided insight into somatically altered genes across tumors, transformed our understanding of cancer biology, and enabled tailoring of …
…, T Marchant, MK Munos, LME Vaz, W Weiss… - BMJ global …, 2019 - gh.bmj.com
Current methods for measuring intervention coverage for reproductive, maternal, newborn, and child health and nutrition (RMNCH+N) do not adequately capture the quality of services …
The disialoganglioside GD2 is overexpressed on several solid tumors, and monoclonal antibodies targeting GD2 have substantially improved outcomes for children with high-risk …
…, M Benvenuti, S Mangani, JD Docquier, WJ Weiss… - 2019 - ACS Publications
A major resistance mechanism in Gram-negative bacteria is the production of β-lactamase enzymes. Originally recognized for their ability to hydrolyze penicillins, emergent β-…
In cancer, recurrent somatic single-nucleotide variants—which are rare in most paediatric cancers—are confined largely to protein-coding genes 1 , 2 – 3 . Here we report highly …
…, MA Kubit, S Greer, WA Weiss… - Blood, The Journal …, 2019 - ashpublications.org
Follicular lymphoma (FL) is a low-grade B-cell malignancy that transforms into a highly aggressive and lethal disease at a rate of 2% per year. Perfect isolation of the malignant B-cell …
Classical novae are thermonuclear explosions that occur on the surfaces of white dwarf stars in interacting binary systems 1 . It has long been thought that the luminosity of classical …
The relative abundance of Wnt receptors plays a crucial role in controlling Wnt signaling in tissue homeostasis and human disease. While the ubiquitin ligases that ubiquitylate Wnt …
… g Kaplan-Meier analysis of overall survival of patients with CTDNEP1 (CTD) mutation and no MYC amplification (CTD w/o MYC), MYC amplification and no CTDNEP1 mutation (MYC w/…